Correlation between platelet-derived microparticles and soluble L-selectin in patients undergoing hemodialysis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Thrombosis and Haemostasis

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1614305PMID 15583756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atherosclerotic and Hemostatic Abnormalities in Patients Undergoing Hemodialysis

  2003cited by this paper
• Significance of platelet activation in vascular access survival of haemodialysis patients.

  2003cited by this paper
• Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients.

  2002cited by this paper
• Development and Assessment of Enzyme Immunoassay for Platelet-derived Microparticles

  2001cited by this paper
• High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells.

  2001cited by this paper
• Function and Clinical Significance of Platelet-Derived Microparticles

  2001cited by this paper
• Hemodialysis access failure: a call to action.

  1998cited by this paper
• Modulation of monocyte-endothelial cell interactions by platelet microparticles.

  1998cited by this paper
• Atherosclerosis and arteriosclerosis in chronic renal failure.

  1997cited by this paper
• Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectin.

  1996cited by this paper
• Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus.

  1995cited by this paper
• A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.

  1995cited by this paper
• Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis

  1994cited by this paper
• Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.

  1994cited by this paper
• Amyloid β-Protein Precursor-Rich Platelet Microparticles in Thrombotic Disease

  1994cited by this paper
• Permanent vascular access: a nephrologist's view.

  1993cited by this paper
• Reduction of platelet glycoprotein Ib in uraemia

  1991cited by this paper
• Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa.

  1990cited by this paper
• Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.

  1988cited by this paper
• Defective platelet adhesion on vessel subendothelium in uremic patients.

  1986cited by this paper

• Clinical Image Hydrophilic Polymer-Coated Polysulfone Membrane Improves Endothelial Function of Hemodialysis Patients : A Pilot Study

  2015cites this paper
• Function and role of microparticles in various clinical settings.

  2008cites this paper
• Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers.

  2006cites this paper